RDS is developing an advanced solid state detector for ionizing radiation. These devices make measurements on a cellular scale and directly measure cellular and/or biological equivalent dosage. RDS' initial objectives are to complete development and commercialization of the current organic detector, capture a portion of the existing radiation detection market, and obtain sufficient funding to achieve self-sustaining net positive cash flow.